Novo Nordisk(US:NVO) Benzinga·2026-01-30 17:31Group 1: Comeback Stocks Overview - The article discusses five stocks with potential for a comeback in 2026, highlighting their poor performance in 2025 and the measures taken to improve in 2026 [1][3] - Each stock has started strong in January, providing investors with time to assess their fit within risk profiles and investment timelines [2] Group 2: Individual Stock Analysis - Novo Nordisk AS: The company, valued at $262 billion, faced a decline of over 40% in 2025 due to competition from Eli Lilly's products and missed revenue estimates. Analysts initiated coverage with a Buy rating and a price target of $73.50, indicating over 20% upside potential [3][4] - UnitedHealth Group Inc.: The company projects over $440 billion in revenue for 2026, with expected EPS exceeding $17.75. The stock had previously broken above the 200-day SMA, but the RSI is currently oversold following its Q4 2025 earnings report [5][6] - Deckers Outdoor Corp.: The stock surged over 14% after its earnings report, trading above both the 50-day and 200-day SMAs for the first time in nearly a year. It has a strong balance sheet and trades at 14 times earnings, earning a Benzinga Edge Quality score of 91.16 [7] - Comcast Corp.: Shares are nearing a breakout as they approach the 200-day SMA, supported by bullish MACD momentum. The stock has been stable, providing quarterly dividends, and a breakout could lead to price appreciation and dividend income [8] - Airbnb Inc.: The company received four upgrades in January, with analysts citing international expansion, the Reserve Now Pay Later service, and the upcoming 2026 World Cup as key growth catalysts. The stock briefly broke out in December but faced a pullback, with a Golden Cross formation indicating potential support at the 50-day SMA [9][10][11]